Viral mutants that selectively replicate in targeted human...

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 7/01 (2006.01) A01N 63/00 (2006.01) A61K 31/711 (2006.01) A61K 35/76 (2006.01) A61K 48/00 (2006.01) C07K 14/075 (2006.01) C12N 7/00 (2006.01) C12N 7/04 (2006.01)

Patent

CA 2449013

Oncolytic viruses are described that have favorable anti-cancer activity and that are produced by random mutagenesis and subsequent bio-selection on cancer cells wherein the viruses are preferably adenoviruses having at least one mutation in the i-leader sequence of the viral major late transcriptional unit.

L'invention se rapporte à des virus oncolytiques qui présentent une activité anticancéreuse positive et qui sont produits par mutagenèse aléatoire et par bio-sélection ultérieure sur des cellules cancéreuses, ces virus étant de préférence des adénovirus présentant au moins une mutation dans la séquence de tête i de la dernière et principale unité de transcription virale.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Viral mutants that selectively replicate in targeted human... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Viral mutants that selectively replicate in targeted human..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Viral mutants that selectively replicate in targeted human... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1855678

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.